All Industries

Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests

Cardio Diagnostics Holdings, Inc

By James Blacker, Benzinga Cardio Diagnostics (NASDAQ: CDIO), the company leveraging AI to revolutionize cardiovascular disease prevention with precision epigenetics, is awaiting a crucial decision that could be a major factor in the commercial success of its flagship heart disease tests. In June of this year, the company attended an annual meeting hosted by the Centers for Medicare and Medicaid Services (CMS), where healthcare companies presented the prices they think Medicare should pay for their products and the rationale for their recommendation. At this meeting, Cardio Diagnostics submitted information and pricing recommendations for its two cutting-edge tests: Epi+Gen CHD and PrecisionCHD. Now, the company is awaiting the next important step – the CMS is expected to release its proposed payment determinations in September, based on the timeline posted by the CMS on its website. These preliminary determinations are based on the information from said annual meeting, public comments and the recommendations from the Clinical Diagnostic Laboratory Tests (CDLT) Advisory Panel. The final determinations are expected in November. "Our cutting-edge tests represent a significant advancement in the prevention, detection and management of coronary heart disease, and we are committed to making them accessible to Medicare beneficiaries," stated Meesha Dogan, PhD, CEO and Co-Founder of Cardio Diagnostics. A Trilogy Of AI-Powered Solutions For Heart Disease According to the CMS, heart disease is the leading cause of death among Medicare beneficiaries. Coronary heart disease (CHD) is the most common type of heart disease and the primary cause of heart attacks, killing 371,506 people in the U.S. in 2022. Recognizing the urgent need for advanced diagnostic tools, Cardio Diagnostics has developed state-of-the-art solutions to assess risk for, detect, manage and monitor CHD. Epi+Gen CHD is an AI-powered blood-based DNA test that evaluates genetic and epigenetic markers to assess the three-year risk for a symptomatic CHD event, while PrecisionCHD aids in diagnosing the condition. Both tests have already been assigned unique CPT codes by the American Medical Association, 0439U and 0440U, respectively, which became effective in April 2024. Coupled with the Epi+Gen CHD and PrecisionCHD tests is the Actionable Clinical Intelligence (ACI) provider-facing platform, which provides personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease. With the crucial decision from the CMS expected this month, Cardio Diagnostics is on the brink of a breakthrough that has the potential to bring its heart disease tests one step closer to being widely accessible to Medicare patients, potentially saving the lives of millions. Click here to find out more about Cardio Diagnostics. Featured photo by Jean-Louis Paulin on Unsplash. Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit www.cardiodiagnosticsinc.com. Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," “goal,” or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company’s ability to compete, regulatory matters, protection of technology, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-K for the period ended December 31, 2022 and Form 10-Q for the period ended March 31, 2023, under the heading “Risk Factors” in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Gene Mannheimer - Investor Relations +1 855-226-9991 investors@cardiodiagnosticsinc.com Company Website https://cardiodiagnosticsinc.com/

September 17, 2024 09:00 AM Eastern Daylight Time

Image

Selling For Maximum Value: An M&A Expert’s Guide To Preparation & Process

Benchmark International

Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

September 17, 2024 09:00 AM Eastern Daylight Time

Video

From Fantasy To Reality: How BullRush's Competitions Can Help You Become A Better Trader

Benzinga

By James Blacker, Benzinga Success in trading takes much more than catching a few lucky winners – becoming consistently profitable requires strategy, discipline and a deep understanding of market dynamics. But how do you develop those skills without risking all of your hard-earned money? While trading simulators offer a low-risk environment in which to practice, traditional platforms often lack excitement and can fail to provide a real incentive to improve your trading. Enter BullRush – a gamified trading platform that combines the excitement of fantasy sports with the learning benefits of simulated trading. The Power Of Competition Competition is known to be an effective driver of human performance and has been associated with improved learning and attention. The desire to outperform others motivates us to continuously sharpen our skills, whether in business, sports or trading. Leveraging this principle, BullRush offers the chance to win real prizes through trading games and tournaments, motivating traders to bring their A-game. Even in free competitions, traders have a strong incentive to perform well because their ranking and stats can be seen by everyone. This adds an extra layer of motivation, as participants are playing not just for prizes, but also to boost their reputation. It is the power of competition that BullRush says sets it apart from simpler trading simulators, which can never fully replicate the emotional intensity of live trading. If there is nothing at stake, it can be tempting to take a reckless approach with too much risk or no clearly defined strategy. Even paying as little as $5 to enter a competition can create a sense of investment that replicates the pressure of real trading, encouraging participants to be more disciplined. With BullRush’s system of rewards, prizes and leaderboards, traders are compelled to take a more measured approach and think carefully about every trade. Learning Through Engagement Another appealing aspect of the BullRush platform is the social interaction it facilitates. Studies have shown that social interaction and sharing experiences can also improve learning and performance. Just as collaboration and feedback are essential in the classroom, interacting with other traders can accelerate the learning curve. Members of the BullRush community can connect via the trade discussion Discord channel, where traders can get together to talk about anything from market projections to strategies, tips, competition results and more. With BullRush, competitions and player profiles are public, which creates another excellent learning opportunity. Traders can review successful trades made by their competitors, gaining insights from their performance. By observing how BullRush’s top-ranked players navigate the markets, new and experienced traders alike can improve their own strategies. BullRush aims to foster a strong community where traders can connect, share strategies and grow alongside like-minded individuals. This social environment makes trading more enjoyable and enriches the learning experience. From Fantasy To Reality The competitive and social benefits of BullRush, combined with the excitement of trading, make it an ideal place to hone your trading skills. The platform’s competitions simulate real market conditions, allowing traders to test out their strategies on a variety of assets, improve trade execution and develop sound risk management skills – all without the pressure of losing real money. Ultimately, BullRush aims to help traders prepare for trading in real live markets by providing a strong foundation of knowledge and skill. Once traders have built up confidence and refined their strategy, they can transition to live trading with everything they learned on the BullRush platform. Whether you are looking to gain experience, test out new strategies or simply enjoy the fun of competing against others, BullRush has something for everyone. Think you’ve got what it takes to take home some prizes? Check out the BullRush fantasy trading platform here! Featured photo courtesy of BullRush. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 17, 2024 08:45 AM Eastern Daylight Time

Image

Amid Volatile Bitcoin Price Landscape, Bitdeer Announces Pricing Of $150 Million Convertible Notes Offering To Fund Continued Growth And Innovation

Benzinga

By Gerelyn Terzo, Benzinga The Bitcoin price has stayed true to its inherently volatile nature of late, straying from its all-time high of $74,000 reached in March. In response, blockchain companies are getting more creative about accessing capital. Bitdeer Technologies Group (NASDAQ: BTDR), a Bitcoin miner and semiconductor design company, has responded by turning to capital markets to support its expanding development pipeline, most recently unveiling the pricing details of a $150 million, five-year convertible bond offering as a means to generate cash flow for its activities. The notes sale was projected to be completed by Aug. 20. Bitdeer also extended the underwriters of the deal a 30-day option to scoop up additional notes in the aggregate principal amount of $22.5 million to offset the potential of over-allotments if demand was greater than anticipated. Bitdeer shares gained following the announcement. The notes, which represent senior, unsecured obligations of Bitdeer, will accrue interest at a rate of 8.50% per year, paid twice per year to holders. With a maturity date of August 2029, the notes will continue to grow unless converted, redeemed or repurchased by the holders, who have the option to convert until close to the maturity date. Based on the conversion rate, the bond is convertible at a 35% premium to Bitdeer stock’s price as of August 15. This means after six months, if the stock price is hovering above that level, investors can convert the bond into equity. The offering was designed for institutional investors who are interested in this asset class, but retail investors might have received an opportunity to participate through mutual funds or exchange-traded funds (ETFs), as well. Bitdeer anticipates net proceeds from the offering of $144.5 million (after discounts, commissions and expenses), translating to a greater $166.3 million upon the exercising of the underwriters’ over-allotment clause. As a leader in all things Bitcoin mining, Bitdeer plans to direct the proceeds of the offering toward its ongoing data center expansion and mining rig development based on its SEALMINER ASIC technology as well as working capital and general corporate purposes. Bitdeer has an ambitious growth strategy, and the company reports it is on pace to become the industry’s first fully integrated Bitcoin miner. At the end of the second quarter, the company had approximately $204 million in cash and $25 million in cryptocurrency on its balance sheet, which in addition to the recent capital markets offerings, should provide it with the working capital it needs to complete its pipeline, including next-generation ASIC chip production as well as its data center expansions. Bitdeer’s recent developments include: Mass production of its SEALMINER A1 chips for Bitcoin mining, with plans to add 3.4 EH/s to its data centers by year-end. Delivery of Bitdeer’s second-generation SEAL02 chip wafers is expected in September, after which time the company plans to ramp up mass production by year-end. Third-generation SEAL03 chip R&D is underway. The company’s ongoing data center projects in the U.S., Norway and Bhutan remain on track as its Bitcoin mining electrical capacity continues to grow. Bitdeer’s 2024 Capital Raising Toolbox Earlier this year, Bitdeer completed a financing deal with stablecoin leader Tether International Limited, comprising a $100 million common stock transaction with the potential for an additional $50 million upon the exercising of warrants. Bitdeer was reportedly pleased to bring a global industry player like Tether to its capital table. BTIG served as the sole bookrunner on the offering. With a market cap close to $1 billion, Bitdeer stock has earned a consensus price target of $14 per share across eight Wall Street analysts. Investors who are bullish on Bitcoin, the blockchain and AI can gain exposure to each of these high-tech segments and more through Bitdeer. Learn more about what the company has to offer here. Featured photo by Elf-Moondance on Pixabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 17, 2024 08:35 AM Eastern Daylight Time

Image

Vuzix (NASDAQ: VUZI) Lands $20 Million Investment From Quanta Computer As The Two Expand Their Smart Glasses Collaboration

Benzinga

By Meg Flippin, Benzinga Vuzix Corp. (NASDAQ: VUZI), the maker of smart glasses and augmented reality (AR) products, just got more firepower to grow thanks to a multimillion-dollar investment from Quanta Computer Inc. (OTC: QUCCF), a global Fortune 500 company and original design manufacturer (ODM). The two already collaborate to advance the smart glasses market and this three-tranche $20 million investment further validates that partnership. The investment by Quanta Computer also strengthens Vuzix’s balance sheet, enabling it to ramp up production of its waveguides and launch new smart glasses and related products. Smart Glasses Getting Smarter Vuzix makes a variety of smart glasses and AR products, including head-mounted smart personal displays and wearable computing devices that offer users a portable high-quality viewing experience. The company’s smart glasses and component technologies are the result of deep R&D and OEM partnerships with technology companies like Quanta Computer. Quanta Computer is a leading notebook manufacturer, cloud computing provider and maker of products for the IT, consumer electronics, cloud computing and smart technology markets such as smart homes. Last year it had revenue of $35 billion, and it has a workforce of about 62,000 employees located around the world. Vuzix says its light, thin and ergonomic waveguide designs combined with its optics technology for display engines sets it apart from its rivals. Vuzix’s waveguides take a projected virtual image and relay it to the eye while expanding the exit pupil (viewing window) at the same time. "Quanta’s investment today represents another important step in our partnership, which has steadily deepened since we first disclosed it last November," said Paul Travers, president and CEO of Vuzix. "This investment, and the ones to follow, will significantly strengthen our balance sheet and assure that we can implement whatever steps needed to ramp production of waveguides, as well as the co-development of new smart glasses and related technologies.” Getting Cash In The Coffers Under the terms of the deal, Quanta will invest $20 million in three tranches. The first tranche will consist of $10 million of Vuzix common stock. The second and third tranches, $5 million each, are tied to specific milestones and will consist of the purchase of Vuzix Series B Preferred Stock. “We plan to work closely with Vuzix to support the AR smart glasses industry and today’s investment in Vuzix represents a strong endorsement of our partnership," said Frank Chuang, Vice President of Quanta Computer. Vuzix said at least $3 million from the investment will go for new product development. Quanta is paying $1.30 per share for the first $10 million of stock. Market In Growth Mode The investment comes at a time when the smart glasses market seems to be taking off and looks poised for growth. The global smart glasses market is forecast to reach $13.68 billion by 2031, growing at a CAGR of 10.3% from 2024 through 2031. Driving the market is demand from manufacturing, warehousing and healthcare companies that use smart glasses to train associates and to provide remote assistance. Monocular smart glasses, which are known to be light and compact, are expected to be a big driver of growth in industries where access to hands-free information is necessary. With these glasses, data and information are overlaid directly on the display. The investment and collaboration should help Vuzik continue to innovate in the marketplace and grow sales. The company said as much when announcing the deepening partnership, saying it looks forward to “realizing the significant” revenue potential it stands to generate in the coming years thanks to the collaboration. Smart glasses are taking off as the use cases continue to grow. Vuzik wants to be a leader and is forging partnerships to make that a reality. Its expanded deal with Quanta Computer underscores that. Not only does it give it $20 million in capital to innovate and expand its offering, but it also offers validation of its technology, given that a computer giant with more than $35 billion in sales has chosen to deepen their partnership. To learn more about the deal and Vuzik, click here. Featured photo courtesy of Vuzix. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 17, 2024 08:30 AM Eastern Daylight Time

Image

New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute

BioMed X Institute

BioMed X, a German biomedical research institute, announced the start of a new research team at the BioMed X Institute in Heidelberg, Germany, the institute’s first joint research project with the Japanese company Ono Pharmaceutical Co., Ltd. The scope of this project is to investigate the antitumor effects of neutrophils to develop novel next-generation immunotherapies. The presence of neutrophils in solid tumors has been well-documented, albeit their role in the tumor microenvironment seems paradoxical according to the current data. “We know far more about T cells in the context of immunotherapy than we know about neutrophils, but distinct immune cell types, including neutrophils, seem to have a potential to exert antitumor effect, while their biology remains unclear. By understanding neutrophil biology in depth, we aim to develop a wider range of effective therapies for cancer patients” explains Dr. Stefanie Bärthel, the group leader of the new research team in partnership with Ono Pharmaceutical. Dr. Bärthel, a Klaus Tschira Boost Fund Fellow in 2023, was a senior scientist at the German Cancer Research Center (DKFZ) in Heidelberg and the Center for Translational Cancer Research (TranslaTUM) in Munich before joining BioMed X as a group leader. “We are delighted to form a team of outstanding scientists with unique ideas on neutrophil-based immunotherapy through our innovative partnership with BioMed X. We believe that the research undertaken by this team will pave the way for the development of groundbreaking treatments,” said Dr. Seishi Katsumata, Corporate Officer/Executive Director, Discovery & Research at Ono Pharmaceutical. “This is our first research team in collaboration with a Japanese company. We are honored by the trust placed in us by Ono Pharmaceutical and look forward to extending our network of collaborators in Japan,” added Dr. Christian Tidona, Founder and Managing Director of the BioMed X Institute. The new research team will join nine other research groups at the BioMed X Institute in Heidelberg, Germany, and two research groups overseas, one at the BioMed X Institute in New Haven, CT, and one at XSeed Labs, a new type of innovation accelerator on the campus of the pharmaceutical company Boehringer Ingelheim in Ridgefield, CT. To read more about research and innovation at BioMed X, visit their website: www.bio.mx. About BioMed X BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun. About Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. ONO focuses its research on oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company’s website at www.ono-pharma.com/en. Contact Details BioMed X Institute Flavia-Bianca Cristian +49 6221 42611706 fbc@bio.mx Company Website https://www.bio.mx/

September 17, 2024 06:00 AM Eastern Daylight Time

Image

Transforming Textiles' Groundbreaking Fashion Line ‘Modality’ to Debut at Milan Fashion Week

Modality

Sweden / ThriveNewsWire / September 16, 2024 / Transforming Textiles AB fashion brand Modality, under the creative direction of Sara Rosberg, is set to make a significant impact on the runways of Milan Fashion Week. The groundbreaking collection themed 'Endangered Animals’ and named “ Fading Fables ” combines innovative Sense-Tex fabric technology, focusing on environmental conservation and sustainable fashion. The collection will be unveiled on September 20th, at Museo Della Scienza in Milan, hosted by Friend of the Earth and the World Sustainability Organization. The runway show, titled “ Beyond the Claim, ” will showcase certified fashion brands and materials by Friend of the Earth, including Sense-tex. Sense-Tex is an innovative biobased 5-fiber yarn technology that combines style, functionality, and sustainability. The Sense-Tex technology, which can be described as a “canvas”, enables sensors (external or embedded) to be applied and integrated onto or inside the fabric to measure vitals. Sense-Tex as a fabric offers health-enhancing benefits and strong ethical values, standing on its own as a sustainable textile without requiring technological integration. Due to pressing upcoming EU regulations affecting the industry, the organizers removed all added sensor tech for this show to focus on the Artistry and Sense-Tex as sustainable fabric. The sensor customization incurs higher costs per unit and requires research and development for each specific sensor project. Therefore, the company is seeking tech partnerships and collaborations with companies that are interested in tailoring their product with sensors to fit their specific needs and budgets. Sense-Tex is a certified material by Friend of the Earth that aligns with the upcoming new EU regulations for the Textile Industry, which requires 10% biobased material in all collections. The multifunctional Sense-Tex yarn and fabric developed by Transforming Textiles ( www.Sense-tex.com ) has also received a “Seal of Excellence ” from the Materials Connexion lab in NYC, where it became part of their exclusive materials library (addressing both the public and private sectors globally). The Sense-Tex yarn/fabric serves various verticals by scaling up the company (Transforming Textiles AB) with subsidiary divisions and a holding structure for the approved IP, as they aim to raise capital to scale up. The Transforming Textiles pitch deck can be reviewed here. This Fading Fables collection by Modality showcases the material's versatility and demonstrates how it can be used in various fashion styles, moods, and genres. Modality is presenting handmade pieces made by Sara Rosberg herself, using scrap fabrics and upcycled garments, combined with prints on Sense-Tex, seamlessly merging art, fashion, and sustainable textile solutions. “The Fading Fables collection is more than just a fashion collection,” says Sara Rosberg. “It tells a story, raises awareness, and highlights the inseparable connection between the future of fashion and the future of our planet. By utilizing upcycled materials and incorporating biobased technologies like Sense-Tex, we not only meet the new EU regulations but also set a new standard for the industry, helping them to transition into the new regulatory landscape.” The theme of the show centres on displacement and the plight of endangered animals, poignantly speaking to the loss of home and the need to flee. As models walk the runway, a powerful video will play in the background, depicting the destruction of animal habitats, the urgent need for conservation, and why we need to support Friend of the Earth and the World Sustainability Organisation. The video was created by Ayesha Saboor, Sara Rosberg, and Charlotte Kehler. The collection will also feature endangered animal-inspired accessories by Charlotte Kehler, made from waste and scrap fabric, with designed artwork printed on Sense-Tex fabric. Modality has partnered with Elobina.com and the Head of Operations, Vilma Gustafsson as a sustainable solution for designers. This collaboration allows Modality to create its own designs and utilize print-on-demand services. By focusing on smaller quantities and producing only what is necessary, this approach fosters a more sustainable production model. Sara Rosberg emphasizes, “ Sustainability is not just a trend, it is a necessity. This collection is more than just fashion; it is a call to action, urging the industry and consumers to embrace a more responsible relationship with our environment." For Buyers We offer the fashion garments showcased on the runway for pre-order sales to boutiques, retailers, and others through our look-book and website www.Modality.store. Please note that due to the complexity of producing Sense-Tex, the estimated delivery time is 5-6 months, but can vary. As some garments have been upcycled by hand, there may be small variations in the sourcing of identical fabrics for larger orders. We want to ensure that the buyers and retailers are aware of this extended timeline, as it differs from traditional textile materials and standard production. We have planned to coordinate bringing smaller orders together with the larger volume orders in one production batch in the coming weeks after MFW. Should we be unable to deliver the combined small quantities due to not reaching the MOQ of 1000kg, Modality will notify you beforehand. Sense-Tex is produced in 3 different factories to ensure the highest quality and performance for safety. A Yarn factory (Kipas), a fabric manufacturer (Ozen Mensucat), and a garment producer (Fethi Tekstil). Due to the brand being in a start-up phase without external funding, there are no fibers in stock, which will delay the production process in this first batch. In the future, when Modality has secured funding, lead times of Sense-Tex will be a maximum of 3 months, when Modality branches out with external funding as a subsidiary of Transforming Textiles AB. Modality also offers options to purchase only the yarn or the fabric in the desired quality, with Minimum Order Quantity (MOQ) requirements (1000kg= 40-60 rolls of fabric approx.) for volume production. These prices include Modality receiving a percentage of the future data revenue if sensors are applied and sold together with Sense-Tex. If there is a preference to order Sense-Tex without this clause when using sensors/tech, we add 20% on top of the current prices stated. However, there are ethical requirements attached from Modality and Transforming Textiles AB in the purchase order agreement to protect the end-user and ensure the handling of data is GDPR compliant and ethical use of the product. If you only wish to buy the fabric and not attach sensors/tech, the prices are as below. For independent designers, we aim to trade Sense-Tex through fabric retailers shortly, enabling purchases of small quantities for slow fashion production. Sense-Tex fabrics and yarns are available in three different compositions: Qty A, Qty B, and Qty C. Each composition caters to different production and manufacturing needs in the Fashion industry, accommodating different focuses and margins. Fabric Prices (Approximately) QTY A: 32EUR/M QTY B: 24 EUR/M QTY C: 21 EUR/M Yarn Prices (Approximately) QTY A: 78EUR/KG QTY B: 57EUR/KG QTY C: 47/EUR/KG **Minimum Order Quantity (MOQ) requirements 1000kg. Contact: We are open to discussing: Partnerships: Licensing: Custom-made designs: Co-Designing: Celebrity projects; Tailored versions of the collection; and any other projects in the creative sector where Sense-Tex could be used combined with storytelling. The Look-Book from the Fading Fables collection can be downloaded on www.Modality.store after the show on the 20th of September. Please email us for these inquiries to: info@modality.store For Tech Partnerships or other vertical projects or collaborations that might be mentioned in the pitch deck, please email: Info@transformingtextiles.com The pitch deck can be reviewed here. For more info on all companies in the Fading Fables project, please visit: www.Modality.store www.Sense-tex.com www. elobina.com www.Ckhelerdesign.se www.Maanaq.com www.friendoftheearth.org www.wso.org Press: Modality and Sara Rosberg will only accept scheduled written interviews at the moment. To request a written interview, please email: Info@transformingtextiles.com Contact Details Modality Sara Rosberg info@modality.store Company Website https://modality.store/

September 16, 2024 11:48 AM Eastern Daylight Time

Join Benchmark International's Exclusive Webinar "Seller Motivation: What Goes Into the Decision to Sell?"

Benchmark International

Are you considering selling your business? Deciding when and why to sell is one of the most significant decisions you’ll ever make as a business owner. While maximizing financial proceeds is often at the forefront of these decisions, it’s essential to recognize that it’s not the only factor. Life circumstances, time with family, and other qualitative considerations can often outweigh financial gain. To help you navigate this complex process, we invite you to join our upcoming webinar: Seller Motivation: What Goes Into The Decision To Sell? Space is filling up fast, so register today! Why You Should Register Selling a business is about more than just crunching the numbers. In this exclusive webinar, you’ll gain valuable insights into the full spectrum of motivations that drive business owners to sell. Understanding these motivations can help you make a well-rounded and informed decision about your business’s future. This webinar is a must-attend for business owners contemplating the sale of their business, particularly in today’s strong but disciplined market. By attending, you’ll be better equipped to evaluate both the financial and personal factors that play a crucial role in this life-changing decision. Whether you’re focused on securing a comfortable financial future or prioritizing time with loved ones, the information presented will help you weigh these considerations effectively. Spots are limited, so don’t miss this opportunity to secure your spot. What You’ll Learn This webinar offers actionable insights into the decision-making process for business owners. Here’s what you can expect to learn: The wide range of reasons why business owners choose to sell, beyond just financial incentives How personal life events, such as family needs and future aspirations, can influence your decision A look at the current M&A market and how buyers are approaching valuations How to balance personal and financial goals using the concept of indifference curves, which help weigh non-monetary values like time with family against financial returns By attending, you’ll gain the tools to make a decision that aligns with your long-term vision—both personally and financially. Spots Are Filling Fast – Register Now! If you’re ready to gain clarity on your motivations for selling and align your decision with both your personal and financial goals, this is the webinar for you. Don’t miss out—register now and take the first step toward making a well-informed, strategic decision about the future of your business. ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

September 16, 2024 09:54 AM Eastern Daylight Time

Image

Moneytree Software Unveils Innovative Financial Planning Solution to Revolutionize Client-Advisor Relationships

Moneytree Software

Moneytree Software has launched a new, game-changing financial planning solution that empowers advisors to capitalize on changing investor expectations and grow their business. Recent research has shown that today’s clients care as much about their relationship with their advisors as they do about their portfolio performance. They value trust and understanding, and they want more consistent and personalized engagement. This is where the new Moneytree solution excels, according to Moneytree Software Managing Director Patrick Spencer. “Long-term success depends on all of us in this industry rethinking how we interact with clients and prospects,” Spencer said. “With this new solution, you have the tools you need to both cultivate more client relationships and develop deeper ones.” Moneytree developed the new cloud-based solution with a focus on the company’s foundational values of accuracy, comprehensiveness, and transparency. Furthermore, the modern interface and intuitive user experience enables advisors to plan with precision in a way that is more satisfying, more time-effective, and more scalable. “With the new Moneytree, you can focus less time on understanding and navigating your planning software and more time on building relationships that grow your business,” Spencer said. Features include: Both goal-based and cash-flow based planning modules to meet the needs of every client, regardless of where they are in their financial journey. Interactive, client-centric reporting tools that help turn insights into action. A wealth of specialized planning tools that save advisors time and money and help them cultivate deeper, more authoritative relationships by supporting retirement planning, income distribution, tax planning, and estate planning. The industry’s only transparent audit trail, which allows you to show highly engaged clients how you arrived at your answers. Advanced analytics that encourage client collaboration and drive better decision-making. In developing the solution, Moneytree spent countless hours on surveys, phone calls, emails, and pouring over market research. Product developers listened to what advisors like about various solutions, and equally importantly, what they found cumbersome. Already, Moneytree’s new solution is receiving rave reviews. “This is one of the best financial planning softwares I have seen, and I have been doing this since 1999,” said Greg Gilbert, CEO of Infinity Financial Services. The new Moneytree is currently available in the comprehensive “Elite” planning package, which replaces the previous Moneytree Plan software. Moneytree is continuing to support Plan, but will no longer sell it. A more streamlined, goals-based-only planning package called “Essential” will become available in early 2025. That product will replace what is currently Moneytree Advise. To learn more, visit moneytree.com. About Moneytree Moneytree Software is an innovator in the development of financial planning technology to support the vital work of financial planners and advisors. The company focuses on empowering professionals with mathematically advanced tools that produce accurate, repeatable results, inspiring trust and confidence. For more than 40 years, Moneytree has delivered the strongest calculation engine in the financial planning and wealth management industry. Contact Details Vocatus Lisa Aldape laldape@vocatusllc.com Company Website https://moneytree.com/

September 16, 2024 09:30 AM Eastern Daylight Time

1 ... 50 51 52 53 54 ... 3765